Overdose and HIV/HCV Prevention for People Who Inject Drugs
This study is testing an intervention to help prevent overdose, HIV (Human Immunodeficiency Virus), and HCV (Hepatitis C Virus) among people who inject drugs. The intervention involves peer education and providing risk reduction materials in places where people inject drugs. Researchers want to see if this approach can reduce risky behaviors. You might be able to join if you are 18 or older, currently use opioids, and do not have a mental or physical health issue that would prevent your participation. The study aims to measure how well it prevents overdose and HIV/HCV at 6 months. The current recruitment status is unclear.
- Study design
- This study is an interventional pilot study, meaning it tests a new approach. Around 285 participants will be randomly assigned to either receive the peer education and materials or standard care.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study measures outcomes related to overdose and HIV/HCV prevention at 6 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Setting Focus Overdose Prevention Intervention
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Carl Latkin, PhD · PRINCIPAL_INVESTIGATOR · Johns Hopkins Bloomberg School of Public Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Overdose prevention6 months
Frequency of carrying naloxone
- HIV/HCV prevention6 months
Frequency of using used cookers